Physician profile
William B Hooper
NPI 1215295084
$2,664.15
in general payments reported to CMS, 2019-2025
16 companies · $77.43 in 2025
The $77.43 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $794 · 2020: $401 · 2021: $661 · 2022: $535 · 2023: $109 · 2024: $86.30 · 2025: $77.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $677.04 | 2019-2023 | Xarelto |
| Pfizer INC. | $512.68 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $325.48 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $271.28 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $191.03 | 2019-2023 | Andexxa |
| Allergan, INC. | $102.85 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $101.65 | 2019 | |
| Abbvie INC. | $96.05 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.39 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $65.25 | 2021-2022 | |
| Abbott Laboratories | $57.42 | 2024 | Cardiomems |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.94 | 2019-2021 | |
| Mylan Specialty L.P. | $47.33 | 2020-2021 | |
| Portola Pharmaceuticals, LLC | $33.22 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.20 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $24.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.